Research advances Progress in the pathogenesis of IgA nephropathy
As the most common primary glomerular disease in the world, IgA nephropathy (IgAN) is one of the major causes of end-stage renal disease (ESRD). With the in-depth studies of IgAN, researchers have gradually clarified the important roles of galactose-deficient IgA1 (Gd-IgA1) production, gut microbiom...
Saved in:
| Main Authors: | Fei-fei Wang, Ling-xu Li, Chun-miao Chen, Xiao-ying Yun, Bing Li |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Nephrology
2024-11-01
|
| Series: | Linchuang shenzangbing zazhi |
| Subjects: | |
| Online Access: | http://www.lcszb.com/cn/article/doi/10.3969/j.issn.1671-2390.2024.11.008 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correlation between serum homocysteine level and clinicopathological factors of IgA nephropathy
by: Cai Xiao-fan, et al.
Published: (2025-01-01) -
IgA Nephropathy: What Is New in Treatment Options?
by: Roberto Scarpioni, et al.
Published: (2024-12-01) -
Lifetime progression of IgA nephropathy: a retrospective cohort study with extended long-term follow-up
by: Mariell Rivedal, et al.
Published: (2025-01-01) -
Thrombotic microangiopathy in IgA nephropathy: pathophysiology, histopathology, and treatment perspectives
by: Ali Rastegar-Kashkouli, et al.
Published: (2024-05-01) -
Thalidomide alleviated IgA nephropathy through “gut-kidney axis”
by: Rui-hua Wang, et al.
Published: (2024-12-01)